DexCom, Inc. vs Mattel Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Mattel Inc trades at $15.03 (market cap $4.30B). The key difference: DexCom, Inc. is far larger — about 7.9× Mattel Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Mattel Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | MAT | |
|---|---|---|
Market Cap | $33.79B | $4.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $22.16 |
52-Week Low | $54.84 | $13.05 |
Enterprise Value | $33.24B | $6.52B |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →